Top-News

Albireo Pharma News

Keine aktuellen Kursdaten verfügbar
WKN: A2DF99
ISIN: US01345P1066
US-Symbol: ALBO
Typ: Aktie

Albireo Pharma News

07.02.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, ALBO, PAYA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, ALBO, PAYA PR Newswire
06.02.23 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations PR Newswire
30.01.23 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations PR Newswire
27.01.23 - PR Newswire
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST PR Newswire
23.01.23 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations PR Newswire
23.01.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, CINC, ALBO, PAYA, GMGI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, CINC, ALBO, PAYA, GMGI PR Newswire
22.01.23 - PR Newswire
Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm
Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm PR Newswire
17.01.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, CINC, ALBO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, CINC, ALBO PR Newswire
16.01.23 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds ALBO, CINC, DCT, and PAYA Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds ALBO, CINC, DCT, and PAYA Shareholders About Its Ongoing Investigations PR Newswire
09.01.23 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc. PR Newswire
09.01.23 - PR Newswire
ALERT: The M&A Class Action Firm Announces the Investigation of Albireo Pharma, Inc. - ALBO
ALERT: The M&A Class Action Firm Announces the Investigation of Albireo Pharma, Inc. - ALBO PR Newswire
09.01.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBO PR Newswire
09.01.23 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Albireo Pharma, Inc. has obtained a Fair Price in its transaction with Ipsen
Shareholder Alert: Ademi LLP investigates whether Albireo Pharma, Inc. has obtained a Fair Price in its transaction with Ipsen PR Newswire
30.11.22 - GlobeNewswire
Reimbursed Access to Bylvay® (odevixibat) Approved in France for Patients with PFIC 1 & 2
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company developing novel bile acid modulators to treat pediatric and adult ...
19.10.22 - GlobeNewswire
Albireo meldet positive Topline-Daten aus Phase-3-Studie zu Bylvay® (Odevixibat) beim Alagille-Syndrom
Hochgradige statistisch signifikante Linderung von Juckreiz, dem primären Endpunkt (p=0,002) Signifikante Verringerung des Gallensäurespiegels im Serum, dem wichtigsten ...
11.10.22 - GlobeNewswire
Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome
Highly statistically significant improvement in pruritus primary endpoint (p=0.002) Significant reductions in key secondary endpoint of serum bile acid levels (p=0.001) Substantial ...
27.09.22 - Wikifolio
Die heißesten Aktien der letzten Woche
In der letzten Woche wurde auf wikifolio.com getradet, was das Zeug hält. Welche Aktien besonders viel ge- und verkauft wurden und welche Motive dafür entscheidend waren, ...
06.09.22 - GlobeNewswire
Italian Medicines Agency Approves Reimbursed Access to Bylvay® (odevixibat) For Patients with All PFIC Types
Positive Agenzia Italiana del Farmaco (AIFA) d ecision provides reimbursed access to the first medicine available for the treatment of all types of PFIC, a rare and devastating ...
15.09.21 - GlobeNewswire
Albireo gibt Verfügbarkeit von Bylvay® (Odevixibat) in Deutschland ab sofort bekannt
– In deutscher Preisliste und allen Apotheken-​Softwareprogrammen aufgeführt –
19.07.21 - PR Newswire
Thinking about buying stock in Albireo Pharma, Ford, Kroger, Carnival Corp, or Bank of America?
Thinking about buying stock in Albireo Pharma, Ford, Kroger, Carnival Corp, or Bank of America? PR Newswire

Newssuche

Videos

newspaper
09:30 Uhr
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »